Q/C Technologies Inc (QCLS) Stock Price, Quote & News

Company Profile

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabi...

Industry: Computer Hardware

Sector: Technology

Phone: 856 848 8698

Website: www.qctechnologies.com

Address:

1185 Avenue of the Americas, Suite 249, New York, United States

ka1954 Aug. 24 at 5:08 PM

$QCLS this fucker is done

1 · Reply

Jj1369 Aug. 24 at 5:02 PM

$QCLS $2.20s also coming today!!! HAHAHA GOING TO ZERO

0 · Reply

ChefCurryStocks Aug. 24 at 4:49 PM

$QCLS

0 · Reply

Kymoneythree Aug. 24 at 4:05 PM

$QCLS RIP. She dead lol. At less than 1% per month to short, it’s an easy hold for $1.00

0 · Reply

Jj1369 Aug. 24 at 3:27 PM

$QCLS LIQUIDATION THEY NEED TO PIVOT TO A NEW FIELD ALREADY 😂😂😂 THE EASIEST SHORT POSITION OF MY LIFE

0 · Reply

Jj1369 Aug. 24 at 3:24 PM

$QCLS $2.30s coming today also!! TAKE IT TO ZEROOOO 😂😂😂

0 · Reply

Jj1369 Aug. 24 at 3:21 PM

$QCLS hahaha this fucking scam is going to zero!!! I tried to tell you dumb fucks it was a blatant worthles scam

0 · Reply

Jj1369 Aug. 24 at 2:36 PM

$QCLS you pathetic losers can’t recover $2.50 😂😂 SHORT IT TO ZERO!!!

0 · Reply

Jj1369 Aug. 24 at 2:28 PM

$QCLS I don’t think it will see $2.80 again 🤡

0 · Reply

Jj1369 Aug. 24 at 2:06 PM

$QCLS you poor losers will never see $3.00 again 😂😂😂

0 · Reply

Q/C Technologies Quarterly report: Q2 2026

Aug 4, 2026, 9:15 AM EDT - 20 days ago

Q/C Technologies Appoints Veteran Silicon Photonics Engineer Yossef Ehrlichman as Founding Manager, Photonic Integrated Circuit (PIC) Development

Jul 1, 2026, 9:44 AM EDT - 7 weeks ago

Q/C Technologies Relocates Headquarters to San Francisco in Proximity to World-Class Engineering Experts for Photonic Computing and Optical AI Inference Initiative

May 15, 2026, 7:00 AM EDT - 3 months ago

Q/C Technologies Quarterly report: Q1 2026

Apr 15, 2026, 7:00 AM EDT - 4 months ago

Q/C Technologies Annual report: Q4 2025

2026-03-18T13:20:54.000Z - 5 months ago

Q/C Technologies launches optical processing unit initiative

Mar 18, 2026, 9:15 AM EDT - 5 months ago

Q/C Technologies Launches Optical Processing Unit (OPU) Initiative to Develop Proprietary Silicon Photonic Computing Architecture for AI Inference

2026-02-11T22:20:14.000Z - 6 months ago

Q/C Technologies files $100M mixed securities shelf

Feb 11, 2026, 7:00 AM EST - 6 months ago

Q/C Technologies Registration statement: Registration Filing

2026-01-20T14:25:11.000Z - 7 months ago

Q/C Technologies appoints Voss to Board of Directors

Jan 20, 2026, 9:15 AM EST - 7 months ago

Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors

2025-12-09T14:40:42.000Z - 9 months ago

Q/C Technologies Inc trading resumes

2025-12-09T14:35:17.000Z - 9 months ago

Q/C Technologies Inc trading halted, volatility trading pause

2025-12-09T14:20:44.000Z - 9 months ago

Q/C Technologies appoints Martin Shkreli as senior advisor

Dec 9, 2025, 9:15 AM EST - 9 months ago

Quantum-Class Computing Developer Q/C Technologies Welcomes Strategic Advisor Martin Shkreli

Dec 4, 2025, 12:05 PM EST - 9 months ago

Martin Shkreli touts QCLS stock as a long idea after a “bad call” on CAPR

Nov 19, 2025, 7:00 AM EST - 9 months ago

Q/C Technologies Quarterly report: Q3 2025

2025-10-30T13:27:23.000Z - 10 months ago

Q/C Technologies enters collaboration with LightSolver

Oct 30, 2025, 9:15 AM EDT - 10 months ago

Q/C Technologies Introduces Proprietary qc-LPU100™ Brand of Quantum-Class Laser Processing Units

Oct 20, 2025, 8:00 AM EDT - 11 months ago

Q/C Technologies Proxy statement: Proxy Filing

2025-10-16T13:25:30.000Z - 11 months ago

Q/C Technologies appoints Steven Frankel as senior quantum advisor

Oct 16, 2025, 9:15 AM EDT - 11 months ago

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Oct 10, 2025, 8:00 AM EDT - 11 months ago

Q/C Technologies Proxy statement: Proxy Filing

2025-10-03T21:35:06.000Z - 11 months ago

Q/C Technologies files to sell 6.51M shares of common stock for holders

Oct 3, 2025, 8:00 AM EDT - 11 months ago

Q/C Technologies Registration statement: Registration Filing

Sep 25, 2025, 9:15 AM EDT - 11 months ago

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Sep 24, 2025, 9:15 AM EDT - 11 months ago

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Sep 17, 2025, 9:24 AM EDT - 1 year ago

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 8, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

Sep 2, 2025, 9:20 AM EDT - 1 year ago

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

PMCB

Sep 2, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

Aug 28, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

Aug 19, 2025, 5:20 PM EDT - 1 year ago

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Aug 19, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Quarterly report: Q2 2025

Jun 24, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

May 19, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

May 15, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Quarterly report: Q1 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

May 8, 2025, 9:20 AM EDT - 1 year ago

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

Apr 22, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Apr 16, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Q/C Technologies Annual report: Q4 2024

Mar 17, 2025, 9:15 AM EDT - 1 year ago

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

Mar 5, 2025, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

Feb 25, 2025, 9:20 AM EST - 1 year ago

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

Jan 29, 2025, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

Jan 15, 2025, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

Dec 19, 2024, 9:15 AM EST - 1 year ago

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Dec 9, 2024, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Nov 14, 2024, 7:00 AM EST - 1 year ago

Q/C Technologies Quarterly report: Q3 2024

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Q/C Technologies Proxy statement: Proxy Filing

Oct 2, 2024, 9:10 AM EDT - 2 years ago

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

Aug 21, 2024, 9:00 AM EDT - 2 years ago

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

ka1954 Aug. 24 at 5:08 PM

$QCLS this fucker is done

1 · Reply

Jj1369 Aug. 24 at 5:02 PM

$QCLS $2.20s also coming today!!! HAHAHA GOING TO ZERO

0 · Reply

ChefCurryStocks Aug. 24 at 4:49 PM

$QCLS

0 · Reply

Kymoneythree Aug. 24 at 4:05 PM

$QCLS RIP. She dead lol. At less than 1% per month to short, it’s an easy hold for $1.00

0 · Reply

Jj1369 Aug. 24 at 3:27 PM

$QCLS LIQUIDATION THEY NEED TO PIVOT TO A NEW FIELD ALREADY 😂😂😂 THE EASIEST SHORT POSITION OF MY LIFE

0 · Reply

Jj1369 Aug. 24 at 3:24 PM

$QCLS $2.30s coming today also!! TAKE IT TO ZEROOOO 😂😂😂

0 · Reply

Jj1369 Aug. 24 at 3:21 PM

$QCLS hahaha this fucking scam is going to zero!!! I tried to tell you dumb fucks it was a blatant worthles scam

0 · Reply

Jj1369 Aug. 24 at 2:36 PM

$QCLS you pathetic losers can’t recover $2.50 😂😂 SHORT IT TO ZERO!!!

0 · Reply

Jj1369 Aug. 24 at 2:28 PM

$QCLS I don’t think it will see $2.80 again 🤡

0 · Reply

Jj1369 Aug. 24 at 2:06 PM

$QCLS you poor losers will never see $3.00 again 😂😂😂

0 · Reply

ChefCurryStocks Aug. 24 at 2:04 PM

$QCLS hahhahaha fucking hilarious

0 · Reply

ChefCurryStocks Aug. 24 at 2:01 PM

$QCLS damn, not even a tiny bit of resistance to all time lows lol. Just opens and dumps. There is zero hope for this scam company.

0 · Reply

Jj1369 Aug. 24 at 1:57 PM

$QCLS going to zero!!! Short this scam to pennyland!!! OFFERING AND RS the only things in the future for this scam!

0 · Reply

Kymoneythree Aug. 24 at 1:48 PM

$QCLS ☠️☠️☠️☠️☠️☠️

0 · Reply

stockboy66 Aug. 24 at 1:42 PM

$QCLS I guess the improvement in earnings doesn’t make a difference.

1 · Reply

Jj1369 Aug. 24 at 1:36 PM

$QCLS not a chance in fucking hell that $2.50 holds ALL TIME LOWS

0 · Reply

HenrikTheBandit Aug. 24 at 7:10 AM

$QCLS been off for a week with salmonella, shitting myself stupid. looks like this one joined in with me on sympathy. Glad to see this board is a complete car crash as usual.

1 · Reply

LindzonForTheOven Aug. 23 at 11:22 PM

$QCLS "easy to borrow even though literally HTB + a ton of shares available to short" "insiders and tutes are dumping" "tutes are writing options against holdings" "it's racist to want Islam out of the West" "stop losses work outside of regular hours" "stocks don't make big moves outside of regular hours" All you sound like is "mmph mmph mmph" the sound of trying to talk with a peenus in your mouth. A ghey Muslim like Obama LOL Raze all mosques to the ground, send all Muslims home in boxes starting with those in gov't and hang all sanctuary city mayors for treason

1 · Reply

USAEquityResearch Aug. 23 at 1:03 PM

$QCLS 📊 USAEquityResearch ▼ 2.58 (-5.49%) Trend: Bearish 📉 RSI (14): 42.3 — neutral territory MACD: bullish, above signal line and rising Volume: normal 📌 Key Levels Resistance: 3.22 | Support: 2.51 20-MA: 2.80 | 50-MA: 3.32 💼 Fundamentals Mkt Cap: $21.13M FCF: $-5.95M (-0.73/sh) Total Debt: $371,171 D/E: 1.95 Educational content only. Not financial advice. Full data, options chain & financials: https://usaequityresearch.com/stocks/QCLS

0 · Reply

LindzonForTheOven Aug. 22 at 12:35 AM

$QCLS it's not gonna happen and you're going to regret your greed for an incredibly long time. Do you really think it would suddenly break 2.50 when it refused to back when e1 thought the pivot was bullshit, and again refused during the scripted hard-V of the last tech earnings? You got lucky blindly following a chart during a flurry of positive catalysts, but 'bro is unlikely to show up to the Summit empty-handed. Likely something significant will have happened by then and/or he'll unveil something while he's there.

1 · Reply

Jj1369 Aug. 21 at 8:40 PM

$QCLS nice close. Looking forward to the break of $2.50 next week

0 · Reply

Kymoneythree Aug. 21 at 8:39 PM

$QCLS you still won’t tell the board what your average is??? Gotta be above $5 as you chased the Shkreli pump back in December. It ran to $8 so you more likely bought the top lol. That was when the float was ~1m shares. Now it’s 8.2m shares and counting. You are too broke to average down. So you need roughly 250% pump to get out lol No wonder you are making multiple accounts to post on this daily with nonsensical ideas and putrid racist opinions. You continue to post about a form3 that literally shows no position held. You think the stock is going to magically move higher after hours… when you can check the tape over the last year and can’t find a single 4hr candle with volume after hours. You are certified delusional. I will eventually close my short for a healthy gain. And a year from now I’ll come back to this board and you’ll still be here. Screaming into the void. Have a fucked weekend.

0 · Reply

Market Cap	21.13M
Revenue (ttm)	0.00
Net Income (ttm)	-11.63M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	187,960
Avg Vol	199,170
Day's Range	N/A - N/A
Shares Out	8.19M
Stochastic %K	2%
Beta	2.16
Analysts	Strong Buy
Price Target	N/A